Health Check: The Future of Healthcare M&A Webinar | SS&C Intralinks

SS&C Intralinks Webinar Series

Title

Health Check: The Future of Healthcare M&A

Webinar Replay

SS&C Intralinks

Header

[Insert Sub Header] - Charting the Al Course: Insights From a Dealmaker Roundtable on Al

Facing persistently high interest rates and a shifting regulatory landscape, healthcare and life sciences dealmakers are rethinking their approaches to inorganic growth.

In this exclusive webinar, industry leaders from corporate development and advisory unpacked the top economic and strategic pressures. Our expert panel explored how corporate and private equity dealmakers are:

Factoring supply chain and tariff disruptions into due diligence
Identifying subsectors drawing renewed investor interest
Navigating evolving antitrust enforcement
Mitigating valuation gaps amid ongoing market uncertainty

Panelists:

Josh Mastracci, Managing Director

TM Capital

Dr. Roby Kanichay, Head of Technologies and Externalizations, Global Business Development

Merck Healthcare KGaA

Daniel Parisotto, PhD, Managing Director, Healthcare Investment Banking

Oppenheimer & Co. Inc.

Elias El Murr, Director of Investment and Business Development

Opella (Sanofi CHC)

Andrew Welch, Vice President - North America, Financial Services

SS&C Intralinks

Moderator:

John Hannan, Director

SS&C Intralinks

Running time:

1 hour

Get the report

Lorem ipsum dolor sit amet lora consectetur adipiscing elit set Nam eget vestibulum sed.